Pharmacy Resources
Read about pharmacy-related safety alerts, announcements and other medication-related information.

News and Alerts 

Medically accepted indication edit PDF opens in new window

Commonly Prescribed Drugs and Formulary Alternatives PDF opens in new window

Drug recall notice for all Akorn drug products PDF opens in new window

Drug Recall Notice for Quinapril Products PDF opens in new window

Drug recall notice for Hizentra PDF opens in new window

Important update on prescription drug coverage for tropicamide eye drops PDF opens in new window

Information about Ivermectin Use PDF opens in new window

Formulary changes for Revlimid PDF opens in new window

FAQ and Information about the launch of generic Xigduo XR PDF opens in new window

FAQ and Information about the launch of generic Farxiga PDF opens in new window

FAQ and Information about the launch of generic Risperdal Consta PDF opens in new window

FAQ and Information about the launch of generic Forteo PDF opens in new window

FAQ and Information about the launch of generic Alphagan PDF opens in new window

FAQ and Information about the launch of generic Spiriva with HandiHaler PDF opens in new window

FAQ and Information about the launch of generic Advair HFA PDF opens in new window 

FAQ and Information about the launch of generic Breo Ellipta PDF opens in new window

FAQ and Information about the launch of generic Flovent PDF opens in new window

FAQ and Information about the launch of generic Restasis PDF opens in new window

FAQ and Information about the launch of generic Combigan PDF opens in new window

FAQ and Information about the launch of generic Mitigare PDF opens in new window

FAQ and Information about the launch of generic Vascepa PDF opens in new window

Nationwide prescription scam targeting healthcare providers PDF opens in new window

FAQ and Information about the launch of generic Symbicort HFA inhaler PDF opens in new window

FAQ and Information About launch of Authorized Generic Insulin Aspart and Insulin Aspart Mix PDF opens in new window

Impact of ongoing angiotensin II receptor blocker (ARB) drug recalls PDF opens in new window

Part D Coverage Determinations 

Find out how to request a coverage determination for a Part D prescription drug and how to access coverage determination request forms. 

How to Request a Coverage Determination or an Exception PDF opens in new window

Prescription Drug Coverage Determination Request Form PDF opens in new window

CarePlus partners with CoverMyMeds to provide real-time determinations for requests submitted online. You can access this service through the link below, registration is required.

Submit request through CoverMyMeds PDF opens in new window

CoverMyMeds flyer PDF opens in new window

If you prefer, you can complete the Coverage Determination Request online in English or Spanish.

You also can access the Medicare Coverage Determination Request Form at the following CMS Part D webpage link: Part D Coverage Determination Request Form

Part B Step Therapy Preferred Drug List 

In August 2018, the Centers for Medicare & Medicaid Services (CMS) rescinded its September 2012 memo “Prohibition on Imposing Mandatory Step Therapy for Access to Part B Drugs and Services.” CMS now allows Medicare Advantage plans to apply step therapy for physician-administered and other Part B drugs. 

Step therapy is a type of pre-authorization for drugs that requires patients to initiate treatment for a medical condition with the most preferred drug therapy. Patients then progress to other therapies, if necessary. 

Due to the 2018 change, CarePlus will require a review of some injectable drugs and biologics for step therapy requirements in addition to current review requirements. The affected drugs/devices are indicated on the Part B Step Therapy Preferred Drug list below. 

2024 Part B Step Therapy Preferred Drug List PDF opens in new window

“Medicare Prescription Drug Coverage and Your Rights” Standardized Pharmacy Notice (CMS-10147) 

CMS requires network pharmacies to distribute the “Medicare Prescription Drug Coverage and Your Rights” notice to beneficiaries. This notice advises Medicare beneficiaries of their rights to contact their plans to obtain a coverage determination or request an exception if they disagree with the information provided by the pharmacist. This notice is provided to Medicare beneficiaries at the point of sale. 

Follow the links below to access this notice in English and Spanish along with form instructions: 

Standardized Pharmacy Notice (CMS-10147) – English PDF opens in new window

Standardized Pharmacy Notice (CMS-10147) – Spanish PDF opens in new window

What do providers need to know about the Inflation Reduction Act (IRA)?

Learn about the Inflation Reduction Act, how it affects patients, and changes to the Part D program.